1) en papers that measured user performance (rate of correct solutions), three reported |
2) single fraction protocol detected reduced rate of "no pain response" (LOR 3.39), gre |
3) ors at 13 of the 15 sites with an overall rate of <1.0 per 10,000 rings dispensed |
4) Aim To investigate the success rate of 'bidirectional' splinting - both i |
5) raw(s), corresponding to a seroconversion rate of 0% (95%CI 0.0-4.1%) over 14.8 pers |
6) 7 hospital readmissions, for an incidence rate of 11.7 per 1,000 discharges. |
7) phosphate buffer, pH 7.5 ± 0.1 at flow rate of 1 ml/min via gradient elution. |
8) Timed-UER events (injury rate of 2.1 injuries/athlete) observed mos |
9) headphone users and has a false-positive rate of 20%. |
10) icare & Medicaid Services to curb the rate of 30-day hospital readmissions for c |
11) s tumor growth in vivo with an inhibitory rate of 49.41%. |
12) Top-sites (48 at a false discovery rate of 5% in the peripheral blood meta-an |
13) Results: The hair survival rate of 58 patients in 10 months post oper |
14) Tensile force was increased at a rate of 5 g/min or held constant for 24 |
15) d they explained the variation in BT at a rate of 69% and estimated with an error ra |
16) model explained the variation in BT at a rate of 73%, estimating with an absolute e |
17) in the variation in BT in Turkey oak at a rate of 91%, indicating species-specific r |
18) ths, respectively, to reach a target cure rate of 93% when receiving standard-dose r |
19) were returned, with an effective response rate of 97.45%. |
20) e effectively received, with s a recovery rate of 97.6%. |
21) id data were obtained, with the effective rate of 98.82%. |
22) onnaires were obtained, with an effective rate of 99.68%. |
23) was limited evidence to suggest a higher rate of ALT normalization with ETV (OR 0.7 |
24) The results show a high detection rate of BFDV in the clinically healthy ca |
25) In this study, the incidence rate of BP increased over 9 years (from 1 |
26) Naproxen demonstrated the lowest rate of Brooker I HO (LOR 2.82), followed |
27) Celecoxib demonstrated the highest rate of Brooker class 0 (LOR 6.96), follow |
28) Celecoxib demonstrated lowest rate of Brooker class II HO (LOR 1.66), cl |
29) The discharge rate of COVID-19 patients was 93.0%, and t |
30) Prediction of the rate of COVID-19 spread and modeling of it |
31) onment significantly increased the uptake rate of DTC and Cu2+ but had no effect on |
32) The relative survival rate of E. |
33) gram-positive bacteria, and the detection rate of Enterococcus was significantly low |
|